Table 2.
Characteristics | No. | Case Patients (n = 20) | Control Subjects (n = 61) | p Value |
---|---|---|---|---|
Recipient variables | ||||
Age, yr | 81 | 49 ± 14 | 54 ± 12 | 0.18 |
Female sex | 81 | 8 (40) | 25 (42) | 0.94 |
Race/ethnicity | 81 | 0.02 | ||
Non-Hispanic white | 15 (75) | 57 (93) | ||
Black | 5 (25) | 3 (5) | ||
Hispanic | 1 (2) | |||
Diagnosis | 81 | 0.03 | ||
COPD | 5 (25) | 32 (52) | ||
Diffuse parenchymal lung disease | 12 (60) | 16 (26) | ||
Cystic fibrosis | 1 (5) | 9 (15) | ||
Other | 2 (10) | 4 (7) | ||
Donor variables | ||||
Age, yr | 81 | 30 ± 13 | 32 ± 14 | 0.69 |
Female sex | 81 | 8 (40) | 25 (41) | 0.94 |
Race/ethnicity | 81 | 0.30 | ||
Non-Hispanic white | 18 (90) | 43 (71) | ||
Black | 8 (13) | |||
Hispanic | 2 (10) | 8 (13) | ||
Other | 2 (3) | |||
Surgical variables | ||||
Bilateral transplant | 81 | 13 (65) | 37 (61) | 0.73 |
Use of CPB | 81 | 14 (70) | 11 (18) | < 0.001 |
mPAP at induction, mm Hg | 61 | 40 ± 14 | 25 ± 9 | < 0.001 |
Ischemic time, min | 77 | 286 (257–375) | 300 (235–352) | 0.50 |
Packed RBCs during first 24 h, mL | 81 | 875 (0–1,500) | 250 (0–750) | 0.05 |
Platelets during first 24 h, mL | 81 | 0 (0–622) | 0 (0–0) | < 0.001 |
Fresh frozen plasma during first 24 h, mL | 81 | 363 (0–1,053) | 0 (0–0) | 0.002 |
Values are given as the mean ± SD, No. (%), or median (IQR), unless otherwise indicated.